A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma

被引：0
|
作者：
Wu, Qunfeng [1 ,2 ]
Pi, Liya [3 ]
Le, Trinh Thu [3 ]
Xia, Chang Qing [3 ]
Liu, Chen [1 ,2 ,3 ]
机构：
[1] Rutgers New Jersey Med Sch, Dept Pathol, Gainesville, FL USA
[2] RWJ Med Sch, Gainesville, FL USA
[3] Univ Florida, Pathol, Gainesville, FL USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1829
引用
收藏
页码：973A / 973A
页数：1
相关论文
共 50 条
  • [41] Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma
    Maurel, M.
    Ladeiro, Y.
    Jalvy-Delvaille, S.
    Pitard, V.
    Vachet, L.
    Combe, C.
    Sagliocco, F.
    Zucman-Rossi, I.
    Laloo, B.
    Grosset, C.
    BULLETIN DU CANCER, 2011, 98 : S43 - S44
  • [42] Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Noncovich, Alain
    Guest, Matt
    Kim, Daniel
    Salvador, Katrina
    Richardson, Samantha
    Miller, Terra
    Han, Guangzhou
    Bhat, Abhijit
    Song, Kenneth
    Li, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 586 - 592
  • [43] Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
    Kaseb, Ahmed Omar
    Hassan, Manal
    Lacin, Sahin
    Abdel-Wahab, Reham
    Amin, Hesham M.
    Shalaby, Ahmed
    Wolff, Robert A.
    Yao, James
    Rashid, Asif
    Vennapusa, Bharathi
    Feng, Janine
    Ohtomo, Toshihiko
    ONCOTARGET, 2016, 7 (43) : 69916 - 69926
  • [44] ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma
    Kelada, O. J.
    Gutsche, N. T.
    Bell, M.
    Berman, R. M.
    Baidoo, K. E.
    Warner, B. M.
    Szajek, L. P.
    Hong, J.
    Ho, M.
    Choyke, P.
    Escorcia, F. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S180 - S181
  • [45] Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
    Shirakawa, Hirofumi
    Suzuki, Hitomi
    Shimomura, Manami
    Kojima, Motohiro
    Gotohda, Naoto
    Takahashi, Shinichiro
    Nakagohri, Toshio
    Konishi, Masaru
    Kobayashi, Nobuaki
    Kinoshita, Taira
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2009, 100 (08): : 1403 - 1407
  • [46] Identification of nanobodies against hepatocellular carcinoma marker glypican-3
    Wang, Wenyi
    Xu, Chang
    Wang, Huanan
    Jiang, Changan
    MOLECULAR IMMUNOLOGY, 2021, 131 : 13 - 22
  • [47] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
    Yukihiro Haruyama
    Hiroaki Kataoka
    World Journal of Gastroenterology, 2016, (01) : 275 - 283
  • [48] The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma
    Orrock, J. M.
    Mounajjed, T.
    Zhang, L.
    Wu, T-T
    LABORATORY INVESTIGATION, 2012, 92 : 421A - 421A
  • [49] The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma
    Orrock, J. M.
    Mounajjed, T.
    Zhang, L.
    Wu, T-T
    MODERN PATHOLOGY, 2012, 25 : 421A - 421A
  • [50] Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
    Fleming, Bryan D.
    Ho, Mitchell
    TOXINS, 2016, 8 (10):
12345